Bulletin
Investor Alert

CRISPR Therapeutics AG

NAS: CRSP

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
CRISPR Therapeutics AG

After Hours

CRSP
/zigman2/quotes/201181046/composite

$

56.00

Change

+0.34 +0.60%

Volume

Volume 9,299

Feb 7, 2023, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/201181046/composite

Today's close

$ 55.51

$ 55.67

Change

+0.16 +0.28%

Day low

Day high

$53.50

$57.22

Open
Open: 56.05

52 week low

52 week high

$38.94

$86.95

Open

Market cap

$4.35B

Average volume

1.09M

P/E ratio

N/A

Rev. per Employee

$29,791

EPS

-8.80

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/crsp

MarketWatch News on CRSP

  1. Here Are the Best Tech ETFs for 2023

    11:31 a.m. Jan. 16, 2023

    - Barron's Online

  2. Thematic ETFs Look Tempting. Just Say No.

    4:01 p.m. Dec. 12, 2022

    - Barron's Online

  3. Crispr Therapeutics started at underweight with $37 stock price target at Morgan Stanley

    8:41 a.m. Oct. 11, 2022

    - Tomi Kilgore

  6. Crispr Therapeutics stock price target raised to $69 from $55 at Stifel Nicolaus

    6:46 a.m. Aug. 9, 2022

    - Tomi Kilgore

  7. Gene-Editor Crispr Therapeutics CEO Sees Positive Catalysts Ahead

    3:25 p.m. June 23, 2022

    - Barron's Online

  8. CRISPR Therapeutics downgraded to in line from outperform at Evercore ISI

    5:23 a.m. June 23, 2022

    - Tomi Kilgore

  9. Crispr Therapeutics started at outperform with $98 stock price target at BMO Capital

    11:23 a.m. June 17, 2022

    - Tomi Kilgore

  10. Roku, Tesla, and Other Cathie Wood Favorites Are Falling

    9:21 a.m. June 13, 2022

    - Barron's Online

  11. FDA Advisors Support the First New Gene Therapy in Nearly 5 Years

    4:36 p.m. June 10, 2022

    - Barron's Online

  12. Crispr Therapeutics stock price target cut to $52 from $64 at Stifel Nicolaus

    7:12 a.m. May 10, 2022

    - Tomi Kilgore

  16. Crispr Therapeutics stock price target cut to $100 from $125 at Evercore ISI

    6:44 a.m. Feb. 17, 2022

    - Tomi Kilgore

  18. 20 Bargain Stocks to Buy Now

    7:38 p.m. Jan. 30, 2022

    - Barron's Online

  20. 4 Beaten-Down Biotech Stocks That Could Take Off

    3:07 p.m. Nov. 17, 2021

    - Barron's Online

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/crsp

Other News on CRSP

  1. This Insider Just Sold Shares of CRISPR Therapeutics AG

    12:30 p.m. Dec. 31, 2022

    - GuruFocus.com

  3. ARKK Bears Are Losing Momentum

    8:04 p.m. Nov. 13, 2022

    - Seeking Alpha

  4. GREENWOOD CAPITAL ASSOCIATES LLC Buys 3, Sells 2 in 3rd Quarter

    2:00 p.m. Nov. 10, 2022

    - GuruFocus.com

  5. Nkarta: Under The Radar Company With Brilliant Results

    12:02 p.m. Nov. 10, 2022

    - Seeking Alpha

  8. Editas Medicine: Q3 Update And 2 Clinical Catalysts To Watch

    6:45 a.m. Nov. 4, 2022

    - Seeking Alpha

  9. Pfizer: Q3 Earnings Review - Planning For Life After COVID

    1:17 p.m. Nov. 3, 2022

    - Seeking Alpha

  12. This Insider Just Sold Shares of CRISPR Therapeutics AG

    12:30 p.m. Oct. 29, 2022

    - GuruFocus.com

  16. bluebird bio: Commercial Success Highly Uncertain

    5:38 a.m. Oct. 26, 2022

    - Seeking Alpha

  17. Vertex (VRTX) to Report Q3 Earnings: What's in the Cards?

    12:34 p.m. Oct. 25, 2022

    - Zacks.com

  18. CRISPR (CRSP) to Report Q3 Earnings: What's in the Cards?

    11:53 a.m. Oct. 25, 2022

    - Zacks.com

  19. Prime Medicine: CRISPR 3.0 Company

    6:52 p.m. Oct. 24, 2022

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/crsp

Press Releases on CRSP

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.